Amgen
Search results
Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while ...
- Responsibility
The Biogen Foundation is committed to advancing better...
- Lupus
Biogen’s decades of study at the crossroads of neurology and...
- Multiple Sclerosis
Multiple sclerosis (MS) is a complex, heterogeneous, chronic...
- Spinal Muscular Atrophy
SMA, an inherited disease that can have a devastating effect...
- Investor Relations
Founded in 1978, Biogen is a leading biotechnology company...
- Pipeline
With a strong focus on difficult-to-treat diseases, our...
- Responsibility
Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while ...
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide.
Jan 31, 2024 · Biogen will focus on LEQEMBI® (lecanemab-irmb) with Eisai and advancing potential new modalities to address the multiple pathologies of the disease and unmet patient needs. A plan for patients participating in clinical trials or on commercially available treatment is in place.
Find the latest Biogen Inc. (BIIB) stock quote, history, news and other vital information to help you with your stock trading and investing.
Find the latest news and updates from Biogen, a biotechnology company focused on neuroscience and rare diseases. See press releases, financial results, clinical trials, and corporate announcements from 2023 to 2024.
Biogen is a global biotechnology company that develops medicines for neurology, neuropsychiatry, immunology and rare diseases. Learn about its history, pipeline, financial performance and stock information on its Investor Relations website.
